BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Carb-X - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://carb-x.org
X-WR-CALDESC:Events for Carb-X
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210126
DTEND;VALUE=DATE:20210129
DTSTAMP:20260403T231129
CREATED:20201202T234806Z
LAST-MODIFIED:20201207T214811Z
UID:4670-1611619200-1611878399@carb-x.org
SUMMARY:4th Annual Texas Medical Center Antimicrobial Resistance and Stewardship Conference
DESCRIPTION:Please make plans to join us for this outstanding line-up of internationally-renowned experts in antimicrobial resistance and stewardship. \nClick here to learn more.\nClick here to view the agenda.\nClick here to register.
URL:https://carb-x.org/event/skip-to-content-4th-annual-texas-medical-center-antimicrobial-resistance-and-stewardship-conference/
LOCATION:VIRTUAL EVENT
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210127
DTEND;VALUE=DATE:20210130
DTSTAMP:20260403T231129
CREATED:20201022T172818Z
LAST-MODIFIED:20201022T172818Z
UID:4503-1611705600-1611964799@carb-x.org
SUMMARY:5th Microbiome Movement - Drug Development Summit Europe 2021
DESCRIPTION:Participants include CARB-X funded companies Eligo Bioscience and Seres Therapeutics. \nAs the first microbiome-based therapeutic steps closer to market approval\, the scientific community continue to demonstrate the functional role of the human microbiome as a novel source of therapeutic\, biomarker and diagnostic development. Despite this progress\, the vast potential to develop effective treatments that target the human microbiome is still limited by the complex challenges in developing them. \nPart of the foremost conference series for microbiome researchers in industry\, the 5th Microbiome Movement – Drug Development Europe 2021 will return to unite leading scientists from the biopharmaceutical and academic community to pursue the causal role of the microbiome in disease\, and help create a new generation of microbiome-targeted therapeutics with predictable modes of action and consistent clinical outcomes. \nTo learn more\, click here.\nTo view the program\, click here.\nTo register\, click here.
URL:https://carb-x.org/event/5th-microbiome-movement-drug-development-summit-europe-2021/
END:VEVENT
END:VCALENDAR